2015, Number 1
<< Back
Rev Hematol Mex 2015; 16 (1)
More about low doses of carfilzomib
Vallejo-Villalobos MF, Reyes-Pérez EN
Language: Spanish
References: 1
Page: 104
PDF size: 317.90 Kb.
Text Extraction
No abstract
REFERENCES
Ruiz-Delgado GJ, Vallejo-Villalobos MF, Galindo Becerra S, Ruiz-Argüelles GJ. Low-dose carfilzomib induced a dramatic response of the symptoms and paraproteinemia in a heavily pre-treated multiple myeloma patient refractory to lenalidomidebortezomib dexametasone. Rev Hematol Mex 2014;15:137-141.